\-\ Texto\\:\\ \ \(0\)\
\-\ alert\\ and\\ oriented\\,\\ with\\ a\\ very\\ hypophonic\\ voice\\ with\\ short\\ one\\ word\\ answers\\.\\ \\ \\ \\ 5\\/5\\ strength\\ in\\ all\\ four\\ extremities\\.\\ reflexes\\ brisk\\ in\\ biceps\\,\\ and\\ knees\\.\\ \\ sensation\\ intact\\ throughout\\.\\ \\ \\ finger\\ to\\ nose\\ intact\\-\\ end\\ point\\ tremor\\,\\ mild\\ dysmetria\\,\\ heel\\ to\\ shin\\ with\\ mild\\ dysmetria\\.\\ gait\\ with\\ two\\ person\\ assist\\ was\\ unsteady\\ with\\ short\\ shuffling\\ steps\\,\\ but\\ after\\ a\\ few\\ steps\\,\\ he\\ remained\\ unsteady\\ but\\ progressed\\ towards\\ a\\ more\\ normal\\ stride\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ labs\\ were\\ significant\\ for\\:\ \(0\)\
\-\ ceruloplasmin\\ \\<6\\ mg\\/dl\ \(0\)\
\-\ copper\\ serum\\ low\\ \\ 34\\ mcg\\/dl\ \(0\)\
\-\ 24\\ hr\\ urine\\ copper\\ level\\ 182\\ mcg\\/day\ \(1\)\
\-\ a\\ liver\\ biopsy\\ showed\\ mild\\ to\\ moderate\\ fibrosis\\ \\(stage\\ 2\\)\\.\\ copper\\ in\\ the\\ liver\\ biopsy\\ paraffin\\ block\\ was\\ high\\ at\\ 350\\.9\\ mcg\\/g\\.\\ \ \(0\)\
\-\ the\\ patient\\ was\\ discharged\\ with\\ glycopyrrolate\\ 1mg\\ tid\\,\\ as\\ needed\\ for\\ drooling\\.\\ his\\ wilson\\'s\\ disease\\ was\\ treated\\ with\\ the\\ copper\\ chelator\\ trientine\\,\\ starting\\ dose\\ of\\ 250\\ mg\\ bid\\,\\ and\\ then\\ increased\\ to\\ 500\\ mg\\ bid\\.\\ the\\ patient\\ was\\ readmitted\\ to\\ the\\ hospital\\ 2\\ months\\ after\\ discharge\\ with\\ worsening\\ mental\\ status\\ and\\ muscle\\ spasms\\.\\ he\\ also\\ had\\ failure\\ to\\ thrive\\,\\ with\\ oropharyngeal\\ dysphagia\\,\\ becoming\\ tube\\ feed\\ dependent\\.\\ his\\ copper\\ serum\\ was\\ low\\ at\\ 17\\ mcg\\/dl\\,\\ and\\ his\\ ceruloplasmin\\ remained\\ low\\ at\\ \\<6\\ mg\\/dl\\.\\ his\\ trientine\\ dose\\ was\\ decreased\\,\\ and\\ a\\ trial\\ of\\ zinc\\ was\\ started\\.\\ no\\ interventions\\ appeared\\ to\\ be\\ helpful\\ in\\ \\ the\\ improvement\\ of\\ his\\ mental\\ status\\,\\ and\\ he\\ passed\\ away\\.\ \(0\)\
\-\ mri\\ of\\ the\\ brain\\ with\\ and\\ without\\ contrast\\:\ \(0\)\
\-\ there\\ is\\ abnormal\\ diffusion\\ restriction\\ with\\ associated\\ t2\\ and\\ flair\\ hyperintensity\\ involving\\ the\\ bilateral\\ thalami\\ with\\ extension\\ into\\ the\\ midbrain\\ and\\ pons\\ as\\ well\\ as\\ the\\ bilateral\\ putamina\\ in\\ a\\ symmetric\\ manner\\.\\ \\ additional\\ diffusion\\ restriction\\ abnormality\\ with\\ associated\\ t2\\ and\\ flair\\ hyperintensity\\ involves\\ the\\ cortex\\ of\\ the\\ bilateral\\ frontal\\ lobes\\,\\ left\\ greater\\ than\\ right\\.\\ \\ low\\ gradient\\ signal\\ is\\ seen\\ in\\ the\\ putamina\\ as\\ well\\.\\ there\\ is\\ no\\ mass\\ effect\\ associated\\ with\\ this\\ abnormal\\ signal\\.\\ no\\ other\\ abnormal\\ parenchymal\\ signal\\ is\\ identified\\.\\ diffuse\\ parenchymal\\ volume\\ loss\\ is\\ also\\ noted\\.\ \(0\)\
\-\ hepatolenticular\\ degeneration\\,\\ wilson\\'s\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ wilson\\'s\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ leigh\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ creutzfeldt\\ jakob\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ carbon\\ monoxide\\ poisoning\ \(0\)\
\-\ \\â\\€\\¢\\ hypoxic\\-ischemic\\ encephalopathy\ \(0\)\
\-\ \\â\\€\\¢\\ pkan\\/nbia\\ \\(hallervorden\\-spatz\\)\ \(0\)\
\-\ this\\ 21\\ y\\.o\\.\\ man\\ presents\\ with\\ several\\ months\\ of\\ progressive\\ apraxia\\,\\ sialorrhea\\,\\ decreased\\ appetite\\,\\ hesitant\\ gait\\,\\ and\\ recent\\ urinary\\ incontinence\\.\\ \\ previous\\ history\\ of\\ asperger\\â\\€\\™s\\ and\\ bipolar\\ affective\\ disorder\\.\ \(0\)\
\-\ this\\ is\\ a\\ classic\\ clinical\\ presentation\\ of\\ wilson\\'s\\ disease\\ that\\ included\\ low\\ cerulosplasmin\\,\\ dysarthria\\,\\ ataxia\\,\\ drooling\\,\\ and\\ urinary\\ incontinence\\.\\ \\ an\\ ocular\\ slit\\-lamp\\ examination\\ was\\ done\\ on\\ this\\ patient\\,\\ but\\ it\\ was\\ not\\ revealing\\ of\\ kayser\\-fleischer\\ rings\\.\\ \ \(0\)\
\-\ youtube\\ \\-\\ http\\:\\/\\/www\\.youtube\\.com\\/watch\\?v\\=p9cmy7gowxw\\&\ \(0\)\
\-\ the\\ classic\\ mri\\ findings\\ found\\ in\\ this\\ patient\\ include\\ bilateral\\,\\ symmetric\\ t2wi\\ hyperintensity\\ of\\ the\\ putamina\\,\\ \\'face\\ of\\ a\\ giant\\ panda\\'\\ in\\ the\\ midbrain\\,\\ and\\ \\'face\\ of\\ a\\ miniature\\ panda\\'\\ in\\ the\\ pontine\\ tegmentum\\.\\ \\ cortical\\ white\\ matter\\ changes\\ have\\ been\\ previously\\ reported\\ in\\ this\\ disease\\ process\\ as\\ well\\,\\ which\\ are\\ seen\\ in\\ the\\ bilateral\\ frontal\\ lobes\\ of\\ this\\ patient\\.\\ \ \(0\)\
\-\ review\\ \\-\\ pmid\\:\\ 15205951\ \(0\)\
\-\ lab\\ diagnosis\\ \\-\\ pmid\\:\\ 18568852\ \(0\)\
\-\ practical\\ approach\\ \\-\\ pmid\\:\\ 17382611\ \(0\)\
\-\ copper\\ \\&\\ iron\\ overload\\ patterns\\ pmid\\:\\ 23338780\ \(0\)\
\-\ references\\:\\ \ \(0\)\
\-\ jacobs\\ da\\,\\ markowitz\\ ce\\,\\ liebeskind\\ ds\\,\\ galetta\\ sl\\.\\ the\\ double\\ panda\\ sign\\ in\\ wilson\\â\\€\\™s\\ disease\\.\\ neurology\\.\\ 2003\\;61\\:969\\.\ \(0\)\
\-\ king\\ ad\\,\\ walshe\\ jm\\,\\ kendall\\ be\\,\\ chinn\\ rj\\,\\ paley\\ mn\\,\\ wilkinson\\ id\\,\\ et\\ al\\.\\ cranial\\ mr\\ imaging\\ in\\ wilson\\â\\€\\™s\\ disease\\.\\ ajr\\ am\\ j\\ roentgenol\\.\\ 1996\\;167\\:1579\\-84\\.\\ \ \(0\)\
\-\ singh\\ p\\,\\ ahluwalia\\ a\\,\\ saggar\\ k\\,\\ grewal\\ cs\\.\\ wilson\\â\\€\\™s\\ disease\\:\\ mri\\ features\\.\\ j\\ pediatr\\ neurosci\\ 2011\\;6\\:27\\-28\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ copper\\:\\ 0\\.06713154273656573\ \(0\)\
\-\ wilson\\:\\ 0\\.06034839125641155\ \(0\)\
\-\ putamina\\:\\ 0\\.039829149505872734\ \(0\)\
\-\ panda\\:\\ 0\\.0366974604370778\ \(0\)\
\-\ pmid\\:\\ 0\\.03241886276795995\ \(0\)\
\-\ ceruloplasmin\\:\\ 0\\.02655276633724849\ \(0\)\
\-\ trientine\\:\\ 0\\.02655276633724849\ \(0\)\
\-\ \\'face\\:\\ 0\\.02655276633724849\ \(0\)\
\-\ mcg\\/dl\\:\\ 0\\.024464973624718535\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.021255924215933072\ \(0\)\
\-\ disease\\:\\ 0\\.021035203933971448\ \(0\)\
\-\ steps\\:\\ 0\\.020691591189491522\ \(0\)\
\-\ dysmetria\\:\\ 0\\.02028938819965862\ \(0\)\
\-\ drooling\\:\\ 0\\.019068107753549692\ \(0\)\
\-\ bid\\:\\ 0\\.018827015260557113\ \(0\)\
\-\ his\\:\\ 0\\.018545851111799187\ \(0\)\
\-\ unsteady\\:\\ 0\\.018395988623085203\ \(0\)\
\-\ low\\:\\ 0\\.017892831723391563\ \(0\)\
\-\ restriction\\:\\ 0\\.017382518030852636\ \(0\)\
\-\ \\,\\:\\ 0\\.01671553115392889\ \(0\)\
\-\ midbrain\\:\\ 0\\.016209431383979976\ \(0\)\
\-\ bilateral\\:\\ 0\\.015616097359295512\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.01538570325087624\ \(0\)\
\-\ \\:\\:\\ 0\\.015319989975777087\ \(0\)\
\-\ incontinence\\:\\ 0\\.0152238503261233\ \(0\)\
\-\ was\\:\\ 0\\.014883697623700103\ \(0\)\
\-\ s\\:\\ 0\\.014763660645268597\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.014482485658837432\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.014159768237312239\ \(0\)\
\-\ mg\\:\\ 0\\.014121638671450021\ \(0\)\
\-\ remained\\:\\ 0\\.014026010062068753\ \(0\)\
\-\ dose\\:\\ 0\\.013469015066604863\ \(0\)\
\-\ hypophonic\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ intact\\-\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ mcg\\/day\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 350\\.9\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ mcg\\/g\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ glycopyrrolate\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ chelator\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ hepatolenticular\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ creutzfeldt\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ jakob\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ pkan\\/nbia\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ sialorrhea\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ affective\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ cerulosplasmin\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ slit\\-lamp\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ kayser\\-fleischer\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ v\\=p9cmy7gowxw\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ miniature\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ tegmentum\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 15205951\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 18568852\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 17382611\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 23338780\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ markowitz\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ liebeskind\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ galetta\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 61\\:969\\.\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ walshe\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ kendall\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ chinn\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 167\\:1579\\-84\\.\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ ahluwalia\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ saggar\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ grewal\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ 6\\:27\\-28\\:\\ 0\\.013276383168624246\ \(0\)\
\-\ \\'\\:\\ 0\\.013066812076771963\ \(0\)\
\-\ parenchymal\\:\\ 0\\.01265180092507602\ \(0\)\
\-\ serum\\:\\ 0\\.012422200426919744\ \(0\)\
\-\ stride\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ paraffin\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ zinc\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ hallervorden\\-spatz\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ asperger\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ paley\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ wilkinson\\:\\ 0\\.012232486812359267\ \(0\)\
\-\ short\\:\\ 0\\.012132610485495339\ \(0\)\
\-\ mental\\:\\ 0\\.012009652670675294\ \(0\)\
\-\ gait\\:\\ 0\\.011985652159683797\ \(0\)\
\-\ urinary\\:\\ 0\\.011914777167484417\ \(0\)\
\-\ flair\\:\\ 0\\.011800236819324057\ \(0\)\
\-\ symmetric\\:\\ 0\\.011755613066959176\ \(0\)\
\-\ j\\:\\ 0\\.011625576404714571\ \(0\)\
\-\ shuffling\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ 182\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ 1mg\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ hesitant\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ ce\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ ds\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ king\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ neurosci\\:\\ 0\\.011621846589304803\ \(0\)\
\-\ diffusion\\:\\ 0\\.011521342883095668\ \(0\)\
\-\ \\'s\\:\\ 0\\.011349678423897861\ \(0\)\
\-\ lobes\\:\\ 0\\.011342356676858317\ \(0\)\
\-\ answers\\:\\ 0\\.011188590456094289\ \(0\)\
\-\ apraxia\\:\\ 0\\.011188590456094289\ \(0\)\
\-\ youtube\\:\\ 0\\.011188590456094289\ \(0\)\
\-\ singh\\:\\ 0\\.011188590456094289\ \(0\)\
\-\ cs\\:\\ 0\\.011188590456094289\ \(0\)\
\-\ \\-\\:\\ 0\\.011034508787399781\ \(0\)\
\-\ abnormal\\:\\ 0\\.011010958917085442\ \(0\)\
\-\ bipolar\\:\\ 0\\.010852530890862045\ \(0\)\
\-\ mn\\:\\ 0\\.010852530890862045\ \(0\)\
\-\ he\\:\\ 0\\.010771930762197377\ \(0\)\
\-\ jacobs\\:\\ 0\\.010577950233039824\ \(0\)\
\-\ tid\\:\\ 0\\.010345795594745761\ \(0\)\
\-\ readmitted\\:\\ 0\\.010345795594745761\ \(0\)\
\-\ sl\\:\\ 0\\.010345795594745761\ \(0\)\
\-\ signal\\:\\ 0\\.010179552697015566\ \(0\)\
\-\ mild\\:\\ 0\\.010166807773785256\ \(0\)\
\-\ this\\:\\ 0\\.010132470622287547\ \(0\)\
\-\ leigh\\:\\ 0\\.00996731000998536\ \(0\)\
\-\ hypoxic\\-ischemic\\:\\ 0\\.00996731000998536\ \(0\)\
\-\ id\\:\\ 0\\.00996731000998536\ \(0\)\
\-\ \\<\\:\\ 0\\.009933932311752382\ \(0\)\
\-\ classic\\:\\ 0\\.00986221349038576\ \(0\)\
\-\ 250\\:\\ 0\\.009808634534597068\ \(0\)\
\-\ 500\\:\\ 0\\.009808634534597068\ \(0\)\
\-\ spasms\\:\\ 0\\.009808634534597068\ \(0\)\
\-\ as\\:\\ 0\\.009733264351612408\ \(0\)\
\-\ word\\:\\ 0\\.009665095107180915\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.009534053876774846\ \(0\)\
\-\ rj\\:\\ 0\\.009534053876774846\ \(0\)\
\-\ feed\\:\\ 0\\.009413507630278557\ \(0\)\
\-\ practical\\:\\ 0\\.009413507630278557\ \(0\)\
\-\ overload\\:\\ 0\\.009413507630278557\ \(0\)\
\-\ jm\\:\\ 0\\.009413507630278557\ \(0\)\
\-\ monoxide\\:\\ 0\\.009301899238480783\ \(0\)\
\-\ pediatr\\:\\ 0\\.009301899238480783\ \(0\)\
\-\ poisoning\\:\\ 0\\.009197994311542602\ \(0\)\
\-\ status\\:\\ 0\\.009187732895125462\ \(0\)\
\-\ \\;\\:\\ 0\\.009150999345418345\ \(0\)\
\-\ biopsy\\:\\ 0\\.009131606149508316\ \(0\)\
\-\ associated\\:\\ 0\\.009110523623076966\ \(0\)\
\-\ voice\\:\\ 0\\.009100797743564332\ \(0\)\
\-\ da\\:\\ 0\\.009100797743564332\ \(0\)\
\-\ \\&\\:\\ 0\\.009040324976329613\ \(0\)\
\-\ tremor\\:\\ 0\\.009009495602274521\ \(0\)\
\-\ becoming\\:\\ 0\\.009009495602274521\ \(0\)\
\-\ roentgenol\\:\\ 0\\.009009495602274521\ \(0\)\
\-\ thrive\\:\\ 0\\.008923413653720383\ \(0\)\
\-\ carbon\\:\\ 0\\.008923413653720383\ \(0\)\
\-\ dysarthria\\:\\ 0\\.008923413653720383\ \(0\)\
\-\ liver\\:\\ 0\\.008874161177207\ \(0\)\
\-\ mri\\:\\ 0\\.00887022223606003\ \(0\)\
\-\ brisk\\:\\ 0\\.008841987115662739\ \(0\)\
\-\ assist\\:\\ 0\\.008841987115662739\ \(0\)\
\-\ manner\\:\\ 0\\.00876473817833209\ \(0\)\
\-\ pontine\\:\\ 0\\.00876473817833209\ \(0\)\
\-\ ad\\:\\ 0\\.00876473817833209\ \(0\)\
\-\ well\\:\\ 0\\.008733799486304145\ \(0\)\
\-\ shin\\:\\ 0\\.008691259015426318\ \(0\)\
\-\ rings\\:\\ 0\\.008691259015426318\ \(0\)\
\-\ \\/\\/www\\.youtube\\.com\\/watch\\:\\ 0\\.008621198750915937\ \(0\)\
\-\ interventions\\:\\ 0\\.008554253325357454\ \(0\)\
\-\ person\\:\\ 0\\.008312773430665919\ \(0\)\
\-\ block\\:\\ 0\\.008312773430665919\ \(0\)\
\-\ revealing\\:\\ 0\\.008312773430665919\ \(0\)\
\-\ in\\:\\ 0\\.008250246975637521\ \(0\)\
\-\ but\\:\\ 0\\.008234201661296103\ \(0\)\
\-\ starting\\:\\ 0\\.00820515450900606\ \(0\)\
\-\ patterns\\:\\ 0\\.00820515450900606\ \(0\)\
\-\ ajr\\:\\ 0\\.00820515450900606\ \(0\)\
\-\ 2011\\:\\ 0\\.008154097955277625\ \(0\)\
\-\ trial\\:\\ 0\\.008104715691989988\ \(0\)\
\-\ thalami\\:\\ 0\\.008104715691989988\ \(0\)\
\-\ iron\\:\\ 0\\.008104715691989988\ \(0\)\
\-\ frontal\\:\\ 0\\.008085216670130594\ \(0\)\
\-\ 1996\\:\\ 0\\.008056901387299354\ \(0\)\
\-\ heel\\:\\ 0\\.007965599246009543\ \(0\)\
\-\ towards\\:\\ 0\\.007965599246009543\ \(0\)\
\-\ neurology\\:\\ 0\\.007838253782111858\ \(0\)\
\-\ gradient\\:\\ 0\\.0077980907593977605\ \(0\)\
\-\ ocular\\:\\ 0\\.0077980907593977605\ \(0\)\
\-\ passed\\:\\ 0\\.007758971050959115\ \(0\)\
\-\ t2wi\\:\\ 0\\.007720841822067111\ \(0\)\
\-\ 6\\:\\ 0\\.007687108919803839\ \(0\)\
\-\ decreased\\:\\ 0\\.007652880731098071\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.00757730239465096\ \(0\)\
\-\ appetite\\:\\ 0\\.007543457732223161\ \(0\)\
\-\ knees\\:\\ 0\\.007477968105807892\ \(0\)\
\-\ away\\:\\ 0\\.007477968105807892\ \(0\)\
\-\ progressed\\:\\ 0\\.007446261164244891\ \(0\)\
\-\ nose\\:\\ 0\\.007415208020867276\ \(0\)\
\-\ pons\\:\\ 0\\.007354959022955079\ \(0\)\
\-\ t2\\:\\ 0\\.00728490592997094\ \(0\)\
\-\ biceps\\:\\ 0\\.00726887707440094\ \(0\)\
\-\ 5\\/5\\:\\ 0\\.007161258152741084\ \(0\)\
\-\ months\\:\\ 0\\.007029943658705022\ \(0\)\
\-\ appeared\\:\\ 0\\.0070130050310343766\ \(0\)\
\-\ k\\:\\ 0\\.0070130050310343766\ \(0\)\
\-\ dependent\\:\\ 0\\.006944014765927008\ \(0\)\
\-\ ataxia\\:\\ 0\\.006878046960718583\ \(0\)\
\-\ finger\\:\\ 0\\.006814847865689921\ \(0\)\
\-\ approach\\:\\ 0\\.006754194403132782\ \(0\)\
\-\ helpful\\:\\ 0\\.006658236851346475\ \(0\)\
\-\ am\\:\\ 0\\.006621502735195633\ \(0\)\
\-\ p\\:\\ 0\\.006603466302896362\ \(0\)\
\-\ end\\:\\ 0\\.006533406038385981\ \(0\)\
\-\ degeneration\\:\\ 0\\.006533406038385981\ \(0\)\
\-\ 2003\\:\\ 0\\.006466460612827497\ \(0\)\
\-\ patient\\:\\ 0\\.0064502404436475\ \(0\)\
\-\ alert\\:\\ 0\\.006418134837900539\ \(0\)\
\-\ 34\\:\\ 0\\.006386758200998668\ \(0\)\
\-\ oriented\\:\\ 0\\.006311062666690101\ \(0\)\
\-\ lab\\:\\ 0\\.006296369632133829\ \(0\)\
\-\ hr\\:\\ 0\\.0062674067376641196\ \(0\)\
\-\ dysphagia\\:\\ 0\\.0062674067376641196\ \(0\)\
\-\ 17\\:\\ 0\\.0062674067376641196\ \(0\)\
\-\ discharge\\:\\ 0\\.006238990345639446\ \(0\)\
\-\ double\\:\\ 0\\.006224980718135962\ \(0\)\
\-\ urine\\:\\ 0\\.006211100213459872\ \(0\)\
\-\ giant\\:\\ 0\\.006197346473153738\ \(0\)\
\-\ reflexes\\:\\ 0\\.006091617167922942\ \(0\)\
\-\ volume\\:\\ 0\\.006078908028396037\ \(0\)\
\-\ improvement\\:\\ 0\\.006004826335337647\ \(0\)\
\-\ involves\\:\\ 0\\.005980920689017933\ \(0\)\
\-\ a\\:\\ 0\\.005972888581605441\ \(0\)\
\-\ included\\:\\ 0\\.005934218525249017\ \(0\)\
\-\ sensation\\:\\ 0\\.005911399541784254\ \(0\)\
\-\ discharged\\:\\ 0\\.0059001184096620285\ \(0\)\
\-\ 21\\:\\ 0\\.005823431526488449\ \(0\)\
\-\ few\\:\\ 0\\.005791724584925448\ \(0\)\
\-\ disorder\\:\\ 0\\.005781302231243861\ \(0\)\
\-\ started\\:\\ 0\\.005740319454850963\ \(0\)\
\-\ fibrosis\\:\\ 0\\.005730245677515426\ \(0\)\
\-\ strength\\:\\ 0\\.005710298046867805\ \(0\)\
\-\ point\\:\\ 0\\.005623665751478969\ \(0\)\
\-\ needed\\:\\ 0\\.005605072625240567\ \(0\)\
\-\ cranial\\:\\ 0\\.005595861439973343\ \(0\)\
\-\ four\\:\\ 0\\.005586706250099274\ \(0\)\
\-\ review\\:\\ 0\\.005577606378930656\ \(0\)\
\-\ 2\\:\\ 0\\.005542483423224537\ \(0\)\
\-\ cortex\\:\\ 0\\.005506721573421641\ \(0\)\
\-\ stage\\:\\ 0\\.005489509682121004\ \(0\)\
\-\ al\\:\\ 0\\.005455665019693205\ \(0\)\
\-\ features\\:\\ 0\\.005430771492658249\ \(0\)\
\-\ tube\\:\\ 0\\.005422564256562519\ \(0\)\
\-\ previously\\:\\ 0\\.0054062827564055685\ \(0\)\
\-\ references\\:\\ 0\\.005350644932321706\ \(0\)\
\-\ done\\:\\ 0\\.005335118773196915\ \(0\)\
\-\ after\\:\\ 0\\.005325304827136152\ \(0\)\
\-\ et\\:\\ 0\\.005267166310425123\ \(0\)\
\-\ at\\:\\ 0\\.005230857618215209\ \(0\)\
\-\ additional\\:\\ 0\\.0051603112863704784\ \(0\)\
\-\ progressive\\:\\ 0\\.0050865046913302755\ \(0\)\
\-\ seen\\:\\ 0\\.005086227756227983\ \(0\)\
\-\ is\\:\\ 0\\.005080940768536677\ \(0\)\
\-\ also\\:\\ 0\\.005074155402620938\ \(0\)\
\-\ worsening\\:\\ 0\\.005066987907230118\ \(0\)\
\-\ matter\\:\\ 0\\.005066987907230118\ \(0\)\
\-\ moderate\\:\\ 0\\.005060538115374694\ \(0\)\
\-\ extremities\\:\\ 0\\.005047720811657964\ \(0\)\
\-\ failure\\:\\ 0\\.005041352835589408\ \(0\)\
\-\ \\?\\:\\ 0\\.005022408886482691\ \(0\)\
\-\ 24\\:\\ 0\\.005003700272027033\ \(0\)\
\-\ previous\\:\\ 0\\.004997515359447736\ \(0\)\
\-\ process\\:\\ 0\\.004954917898847461\ \(0\)\
\-\ http\\:\\ 0\\.004873175599367886\ \(0\)\
\-\ hospital\\:\\ 0\\.00484502479663874\ \(0\)\
\-\ greater\\:\\ 0\\.0048339101772146105\ \(0\)\
\-\ throughout\\:\\ 0\\.004817390551656516\ \(0\)\
\-\ abnormality\\:\\ 0\\.004747828228660471\ \(0\)\
\-\ intact\\:\\ 0\\.004727055153159965\ \(0\)\
\-\ cortical\\:\\ 0\\.004691377787011765\ \(0\)\
\-\ reported\\:\\ 0\\.004691377787011765\ \(0\)\
\-\ very\\:\\ 0\\.004671363883218568\ \(0\)\
\-\ muscle\\:\\ 0\\.004622462700943291\ \(0\)\
\-\ identified\\:\\ 0\\.004598594941545665\ \(0\)\
\-\ extension\\:\\ 0\\.004593866447562731\ \(0\)\
\-\ then\\:\\ 0\\.004579769395213991\ \(0\)\
\-\ effect\\:\\ 0\\.004556563634140429\ \(0\)\
\-\ involving\\:\\ 0\\.004515673590366406\ \(0\)\
\-\ to\\:\\ 0\\.004502224034790518\ \(0\)\
\-\ labs\\:\\ 0\\.004475864468275811\ \(0\)\
\-\ sign\\:\\ 0\\.004458503767716974\ \(0\)\
\-\ presentation\\:\\ 0\\.004432832280860064\ \(0\)\
\-\ recent\\:\\ 0\\.00432638410969849\ \(0\)\
\-\ white\\:\\ 0\\.0042682292360120755\ \(0\)\
\-\ showed\\:\\ 0\\.004219583234824844\ \(0\)\
\-\ several\\:\\ 0\\.004137188005606005\ \(0\)\
\-\ mr\\:\\ 0\\.00408915583124463\ \(0\)\
\-\ and\\:\\ 0\\.004066468502986862\ \(0\)\
\-\ found\\:\\ 0\\.004055761467548362\ \(0\)\
\-\ examination\\:\\ 0\\.004000637101618321\ \(0\)\
\-\ be\\:\\ 0\\.003969146757060027\ \(0\)\
\-\ clinical\\:\\ 0\\.003959803915762055\ \(0\)\
\-\ the\\:\\ 0\\.003955928327362786\ \(0\)\
\-\ diffuse\\:\\ 0\\.003896095512613426\ \(0\)\
\-\ no\\:\\ 0\\.0038875488736617556\ \(0\)\
\-\ brain\\:\\ 0\\.0038725173543716295\ \(0\)\
\-\ treated\\:\\ 0\\.003852184994102198\ \(0\)\
\-\ there\\:\\ 0\\.003830468543569243\ \(0\)\
\-\ loss\\:\\ 0\\.0037356388139584934\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0037144268563052713\ \(0\)\
\-\ level\\:\\ 0\\.0037091702223598375\ \(0\)\
\-\ changes\\:\\ 0\\.003688325265414248\ \(0\)\
\-\ two\\:\\ 0\\.003685739815686756\ \(0\)\
\-\ all\\:\\ 0\\.0036399450142037514\ \(0\)\
\-\ include\\:\\ 0\\.0036101709157082633\ \(0\)\
\-\ high\\:\\ 0\\.0035219067184891805\ \(0\)\
\-\ been\\:\\ 0\\.0035011971226867338\ \(0\)\
\-\ one\\:\\ 0\\.0034875472640220543\ \(0\)\
\-\ significant\\:\\ 0\\.003460613179298529\ \(0\)\
\-\ than\\:\\ 0\\.0033720615284913765\ \(0\)\
\-\ more\\:\\ 0\\.0032186390200484435\ \(0\)\
\-\ increased\\:\\ 0\\.003148320454517554\ \(0\)\
\-\ into\\:\\ 0\\.003062238505963414\ \(0\)\
\-\ noted\\:\\ 0\\.0030503331151394484\ \(0\)\
\-\ man\\:\\ 0\\.0030435720528463844\ \(0\)\
\-\ without\\:\\ 0\\.0030301403107803617\ \(0\)\
\-\ imaging\\:\\ 0\\.003015171422372896\ \(0\)\
\-\ other\\:\\ 0\\.002966323115515736\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0029551495945488253\ \(0\)\
\-\ were\\:\\ 0\\.0029221179769426528\ \(0\)\
\-\ it\\:\\ 0\\.002892843952609965\ \(0\)\
\-\ contrast\\:\\ 0\\.0028806862753131108\ \(0\)\
\-\ have\\:\\ 0\\.0027868043348871865\ \(0\)\
\-\ had\\:\\ 0\\.002776882257892633\ \(0\)\
\-\ findings\\:\\ 0\\.0027392122526957224\ \(0\)\
\-\ with\\:\\ 0\\.0026431666285366656\ \(0\)\
\-\ presents\\:\\ 0\\.0026289823727529004\ \(0\)\
\-\ which\\:\\ 0\\.002402326185606248\ \(0\)\
\-\ of\\:\\ 0\\.0022809479071895324\ \(0\)\
\-\ that\\:\\ 0\\.0022228625430102764\ \(0\)\
\-\ for\\:\\ 0\\.0021961088814539615\ \(0\)\
\-\ \\(\\:\\ 0\\.002175788332059821\ \(0\)\
\-\ \\)\\:\\ 0\\.002149209916003931\ \(0\)\
\-\ normal\\:\\ 0\\.0020174886364444293\ \(0\)\
\-\ \\.\\:\\ 0\\.0019781368006051387\ \(0\)\
\-\ not\\:\\ 0\\.0018596666743101438\ \(0\)\
\-\ mass\\:\\ 0\\.0017898509140776575\ \(0\)\
\-\ an\\:\\ 0\\.0017796157594649547\ \(0\)\
\-\ history\\:\\ 0\\.0017774315326913907\ \(0\)\
\-\ are\\:\\ 0\\.0017543281212795208\ \(0\)\
\-\ left\\:\\ 0\\.0014399175742061969\ \(0\)\
\-\ right\\:\\ 0\\.0013578790799855674\ \(0\)\
\-\ on\\:\\ 0\\.001090197307779259\ \(0\)\
